TWO · 6518.TWO
Concord Medical Co., Ltd.
NT$30.15NT$0.00 (0.0%)
Concord Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.75% below the high.
Loading market information…
TWO · 7561.TWO · TWD
Stock price, dividends
Quote as of Oct 30, 2026, 06:54 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Bioray Biotech Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 33.91% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
THE COMPANY BEHIND THE TICKER
Bioray Biotech Co., Ltd is dedicated to the innovation, manufacturing, and distribution of biological and health supplement products. The company's biological offerings span specialized functional probiotics, therapeutic fungi, and immune cell preparations. Additionally, Bioray Biotech extends its expertise to the field of cellular testing and preservation services. Founded in 1994, this Taiwanese firm is based in Pingtung.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:43 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$30.15NT$0.00 (0.0%)
Concord Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.75% below the high.
NT$14.60-NT$0.35 (-2.34%)
Original BioMedicals Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 27.0% below the high.
NT$28.35NT$0.00 (0.0%)
BioLASCO Taiwan Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 12.5% below the high.
NT$33.10+NT$0.25 (+0.76%)
Sofiva Genomics Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.25% below the high.
NT$18.65NT$0.00 (0.0%)
TFBS Bioscience Inc.’s quoted price sits in the lower half of its reported 52-week range, 33.03% below the high.
NT$18.05+NT$0.05 (+0.28%)
EBM Technologies Incorporated’s quoted price sits in the lower half of its reported 52-week range, 27.66% below the high.
NT$6.79-NT$0.04 (-0.59%)
TaiwanJ Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.71% below the high.
NT$12.00NT$0.00 (0.0%)
Vectorite Biomedical Inc.’s quoted price sits in the lower half of its reported 52-week range, 33.88% below the high.
